Microvascular responses to cardiovascular risk factors.

Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol (2015) 1.19

Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med (2011) 1.17

Microfluidic devices for modeling cell-cell and particle-cell interactions in the microvasculature. Microvasc Res (2011) 1.15

Marine carotenoids and cardiovascular risk markers. Mar Drugs (2011) 1.03

Interaction between maternal and offspring diet to impair vascular function and oxidative balance in high fat fed male mice. PLoS One (2012) 0.99

Large conductance, calcium- and voltage-gated potassium (BK) channels: regulation by cholesterol. Pharmacol Ther (2012) 0.96

Interleukin-1 and acute brain injury. Front Cell Neurosci (2015) 0.95

Blood cells and endothelial barrier function. Tissue Barriers (2015) 0.94

Impaired leptomeningeal collateral flow contributes to the poor outcome following experimental stroke in the Type 2 diabetic mice. J Neurosci (2015) 0.92

Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis. Hypertension (2011) 0.90

Retinal vascular caliber is associated with cardiovascular biomarkers of oxidative stress and inflammation: the POLA study. PLoS One (2013) 0.89

Mononuclear cell therapy reverts cuff-induced thrombosis in apolipoprotein E-deficient mice. Lipids Health Dis (2012) 0.88

Tissue factor and obesity, a two-way street. Nat Med (2011) 0.88

Eprosartan improves cardiac function in swine working heart model of ischemia-reperfusion injury. Med Sci Monit Basic Res (2014) 0.87

Chronic hindlimb ischemia impairs functional vasodilation and vascular reactivity in mouse feed arteries. Front Physiol (2011) 0.82

Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure. Hypertension (2012) 0.82

Antioxidative diet supplementation reverses high-fat diet-induced increases of cardiovascular risk factors in mice. Oxid Med Cell Longev (2015) 0.81

Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes. Ann Surg (2013) 0.79

Impaired vasomotor function induced by the combination of hypertension and hypercholesterolemia. J Am Soc Hypertens (2013) 0.79

Inflammogenesis of Secondary Spinal Cord Injury. Front Cell Neurosci (2016) 0.78

Obligatory role of intraluminal O2- in acute endothelin-1 and angiotensin II signaling to mediate endothelial dysfunction and MAPK activation in guinea-pig hearts. Int J Mol Sci (2014) 0.78

Hypercholesterolemia blunts the oxidative stress elicited by hypertension in venules through angiotensin II type-2 receptors. Microvasc Res (2016) 0.77

Doppler flowmetry as a tool of predictive, preventive and personalised dentistry. EPMA J (2013) 0.77

Resolution of Acute Inflammation and the Role of Resolvins in Immunity, Thrombosis, and Vascular Biology. Circ Res (2016) 0.76

Frontiers in microcirculation: control processes and clinical applications. Microcirculation (2010) 0.75

NF-κB-dependent airway inflammation triggers systemic insulin resistance. Am J Physiol Regul Integr Comp Physiol (2015) 0.75

Ipsilateral Infarct in Newly Diagnosed Cervical Internal Carotid Artery Atherosclerotic Occlusion. Interv Neurol (2015) 0.75

Chronic Stress Facilitates the Development of Deep Venous Thrombosis. Oxid Med Cell Longev (2015) 0.75

Joint Effect of Early Microvascular Damage in the Eye &Kidney on Risk of Cardiovascular Events. Sci Rep (2016) 0.75

Observational study of the effects of age, diabetes mellitus, cirrhosis and chronic kidney disease on sublingual microvascular flow. Perioper Med (Lond) (2013) 0.75

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res (2000) 10.95

Role of endothelial dysfunction in atherosclerosis. Circulation (2004) 5.77

Retinal angiogenesis in development and disease. Nature (2005) 4.18

Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res (2007) 3.96

Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes (2007) 3.87

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev (2007) 3.19

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med (2003) 2.94

In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J Clin Invest (2008) 2.78

Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol (1997) 2.53

Diabetes mellitus: a hypercoagulable state. J Diabetes Complications (2001) 2.51

Adipose tissue angiogenesis. J Anim Sci (2004) 2.49

Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A (2001) 2.11

Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo. J Clin Invest (2007) 2.03

Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol (2004) 1.98

Oxidative stress and hypertension. Med Clin North Am (2009) 1.95

Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev (2008) 1.91

Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology (2009) 1.91

Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest (1998) 1.87

Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A. Arterioscler Thromb Vasc Biol (2007) 1.85

Role of blood cell-associated AT1 receptors in the microvascular responses to hypercholesterolemia. Arterioscler Thromb Vasc Biol (2005) 1.73

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis. Circulation (2002) 1.72

Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol (2006) 1.56

Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes (2006) 1.56

Angiogenic growth factors and hypertension. Angiogenesis (2004) 1.50

Angiogenesis and obesity. Cardiovasc Res (2007) 1.49

Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest (2001) 1.41

Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes (2004) 1.36

Inflammatory and injury responses to ischemic stroke in obese mice. Stroke (2008) 1.36

Role of adipose tissue in haemostasis, coagulation and fibrinolysis. Obes Rev (2009) 1.32

Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med (2002) 1.32

Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol (2005) 1.28

Obesity increases blood pressure, cerebral vascular remodeling, and severity of stroke in the Zucker rat. Hypertension (2008) 1.24

Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Microcirculation (2007) 1.24

Elevated ambient glucose induces acute inflammatory events in the microvasculature: effects of insulin. Am J Physiol Endocrinol Metab (2001) 1.23

NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circ Res (2001) 1.22

The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation (2002) 1.19

Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta (1998) 1.18

Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens (2005) 1.18

Advanced glycosylation end products induced tissue factor expression in human monocyte-like U937 cells and increased tissue factor expression in monocytes from diabetic patients. Atherosclerosis (1998) 1.16

Cerebral microvascular responses to hypercholesterolemia: roles of NADPH oxidase and P-selectin. Circ Res (2003) 1.16

Is hypertension an immunologic disease? Curr Cardiol Rep (2008) 1.15

Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury. Am J Physiol Heart Circ Physiol (2004) 1.15

Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress. Antioxid Redox Signal (2009) 1.14

Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain. FASEB J (2006) 1.14

Adipose tissue: a motor for the inflammation associated with obesity. IUBMB Life (2009) 1.12

Diabetes exacerbates inflammatory responses to ischemia-reperfusion. Circulation (1996) 1.10

Platelet dysfunction in central obesity. Nutr Metab Cardiovasc Dis (2009) 1.07

Modulation of the inflammatory response in cardiovascular disease. Hypertension (2004) 1.06

Microcirculation and oxidative stress. Free Radic Res (2007) 1.06

High pressure promotes monocyte adhesion to the vascular wall. Circ Res (2007) 1.05

The role of renin-angiotensin system in prothrombotic state in essential hypertension. Physiol Res (2009) 1.05

Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature. Am J Physiol Heart Circ Physiol (2007) 1.04

The impairment of preconditioning-mediated cardioprotection in pathological conditions. Pharmacol Res (2009) 1.03

The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia? J Physiol (2004) 0.99

Adiponectin protects against angiotensin II or tumor necrosis factor alpha-induced endothelial cell monolayer hyperpermeability: role of cAMP/PKA signaling. Arterioscler Thromb Vasc Biol (2008) 0.99

Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo. Diabetes (2002) 0.99

Early changes in coronary artery wall structure detected by microcomputed tomography in experimental hypercholesterolemia. Am J Physiol Heart Circ Physiol (2007) 0.99

Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension (2009) 0.99

Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function. Arterioscler Thromb Vasc Biol (2003) 0.98

CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation. Am J Physiol Heart Circ Physiol (2008) 0.97

Impact of obesity and insulin resistance on vasomotor tone: nitric oxide and beyond. Clin Exp Pharmacol Physiol (2006) 0.96

Oxidative stress and diabetic vascular complications. Curr Diab Rep (2004) 0.96

Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovasc Res (2003) 0.96

Tea polyphenols regulate nicotinamide adenine dinucleotide phosphate oxidase subunit expression and ameliorate angiotensin II-induced hyperpermeability in endothelial cells. Hypertens Res (2003) 0.95

Antioxidants attenuate hyperglycaemia-mediated brain endothelial cell dysfunction and blood-brain barrier hyperpermeability. Diabetes Obes Metab (2008) 0.95

Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients. Am J Hypertens (2001) 0.94

Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J Hypertens (2000) 0.94

Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy. J Cereb Blood Flow Metab (2008) 0.94

Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo. Arterioscler Thromb Vasc Biol (2004) 0.93

Vascular permeability, blood pressure, and organ damage in primary hypertension. Hypertens Res (2008) 0.93

Crosstalk between inflammation and thrombosis. Maturitas (2009) 0.93

A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury. Basic Res Cardiol (2005) 0.93

Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes. Stroke (2008) 0.91

Platelet activation by low density lipoprotein and high density lipoprotein. Pathophysiol Haemost Thromb (2006) 0.90

Microvascular responses to hypercholesterolemia: the interactions between innate and adaptive immune responses. Antioxid Redox Signal (2006) 0.88

Platelet-associated NAD(P)H oxidase contributes to the thrombogenic phenotype induced by hypercholesterolemia. Free Radic Biol Med (2007) 0.88

Endothelin-1, aging and hypertension. Curr Opin Cardiol (2008) 0.88

The leptin receptor system of human platelets. J Thromb Haemost (2005) 0.88

Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review. Blood Cells Mol Dis (2008) 0.87

Endothelial control of vasomotor function: from health to coronary disease. Circ J (2003) 0.86

Platelet function in hypertension. Blood Cells Mol Dis (2008) 0.85

Simvastatin, capillary permeability, and acetylcholine-mediated vasomotion in atherosclerotic, hypercholesterolemic men. Clin Pharmacol Ther (2000) 0.84

Microvascular responses to ischemia/reperfusion in normotensive and hypertensive rats. Hypertension (1999) 0.84

Reactive oxygen species mediate angiotensin II-induced leukocyte-endothelial cell interactions in vivo. J Leukoc Biol (2001) 0.83

Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon. FASEB J (2004) 0.83

Whole blood aggregation and coagulation in db/db and ob/ob mouse models of type 2 diabetes. Blood Coagul Fibrinolysis (2008) 0.83

Hypercholesterolemia enhances oxidant production in mesenteric venules exposed to Ischemia/Reperfusion. Arterioscler Thromb Vasc Biol (1998) 0.82

Angiotensin II type 1 receptors and the intestinal microvascular dysfunction induced by ischemia and reperfusion. Am J Physiol Gastrointest Liver Physiol (2006) 0.82

Reperfusion-induced oxidative stress in diabetes: cellular and enzymatic sources. J Leukoc Biol (1999) 0.81

Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemia. Atherosclerosis (2003) 0.81

Whole blood aggregation, coagulation, and markers of platelet activation in diet-induced diabetic C57BL/6J mice. Diabetes Res Clin Pract (2009) 0.81

Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: implications for reactive oxygen species. Pharmacol Rep (2009) 0.79

Prothrombotic megakaryocyte and platelet changes in hypertension are reversed following treatment: a pilot study. Platelets (2001) 0.78

Chronic expression of platelet adhesion proteins is associated with severe ischemic heart disease in type 2 diabetic patients: Chronic platelet activation in diabetic heart patients. J Diabetes Complications (2003) 0.78

The upregulation of ICAM-1 and P-selectin requires high blood pressure but not circulating renin-angiotensin system in vivo. J Hypertens (2004) 0.78

Hypersensitivity to ADP of platelets from diabetic rats associated with enhanced fibrinogen binding. Eur J Clin Invest (1992) 0.77

Low-density lipoprotein-lowering medication and platelet function. Pathophysiol Haemost Thromb (2006) 0.77

Life and death in the microcirculation: a role for angiotensin II. Microcirculation (1998) 0.76

Does hypertension confer a hypercoagulable state? J Hypertens (1998) 0.76

Angiotensin-II-induced increase in transcoronary protein clearance: role of hypertension vs. nitric oxide or cyclo-oxygenase products. Cardiovasc Res (1995) 0.76

Fractional particle swarm optimization in multidimensional search space. IEEE Trans Syst Man Cybern B Cybern (2009) 1.34

Interleukin-1beta mediates the extra-intestinal thrombosis associated with experimental colitis. Am J Pathol (2010) 0.97

Platelet abnormalities during colonic inflammation. Inflamm Bowel Dis (2013) 0.87

Leukocyte-dependent responses of the microvasculature to chronic angiotensin II exposure. Hypertension (2012) 0.82

Evolutionary artificial neural networks by multi-dimensional particle swarm optimization. Neural Netw (2009) 0.79

Impaired vasomotor function induced by the combination of hypertension and hypercholesterolemia. J Am Soc Hypertens (2013) 0.79

Effect of high-fat intake on motor activity, homovanillic acid and 5-hydroxyindoleacetic acid levels in striatum and cortex of rats exposed to stress. Nutr Neurosci (2009) 0.77

Lipid-Core Nanocapsules Act as a Drug Shuttle Through the Blood Brain Barrier and Reduce Glioblastoma After Intravenous or Oral Administration. J Biomed Nanotechnol (2016) 0.76

MyD88 mediates the protective effects of probiotics against the arteriolar thrombosis and leukocyte recruitment associated with experimental colitis. Inflamm Bowel Dis (2015) 0.75

The involvement of nitric oxide and endothelin-1 in exercise-induced bronchospasm in young soccer players. Clin J Sport Med (2011) 0.75

Rare variation of the celiac trunk and related review. Saudi Med J (2005) 0.75